385
Views
4
CrossRef citations to date
0
Altmetric
Reviews

Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST)

, &
Pages 341-348 | Published online: 28 Dec 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Steven D. Scoville, Jordan M. Cloyd & Timothy M. Pawlik. (2020) New and emerging systemic therapy options for well-differentiated gastroenteropancreatic neuroendocrine tumors. Expert Opinion on Pharmacotherapy 21:2, pages 183-191.
Read now
Yi Liu, Fuxiang Zhou, Kuicheng He, Ting Cheng, Zhi Zhong, Yingle Liu & Yi Yang. (2018) Design, synthesis and biological evaluation of 3-fluoroalkenyloxindole ring-fused 3-trifluoromethyloxindoles obtained from indoline-2,3-diones and difluoromethylene phosphabetaine. Phosphorus, Sulfur, and Silicon and the Related Elements 193:4, pages 201-205.
Read now
Anna M Czarnecka, Cezary Szczylik & Brian Rini. (2014) The use of sunitinib in renal cell carcinoma: where are we now?. Expert Review of Anticancer Therapy 14:9, pages 983-999.
Read now
Sandrine Faivre & Eric Raymond. (2008) Mechanism of action of rapalogues: the antiangiogenic hypothesis. Expert Opinion on Investigational Drugs 17:11, pages 1619-1621.
Read now